Zydus Lifesciences Stock Soars to New High, Outperforms Sector and Sensex.

Zydus Lifesciences, a leading pharmaceutical company in the largecap industry, has seen a positive growth in its stock price. On May 21, 2024, the company's stock gained 3.08%, closing at Rs. 1171.95, which is also its new 52-week and all-time high. This performance has been recognized by MarketsMOJO, who have given a 'Buy' call for the stock. The stock has been on a consecutive rise for the last 5 days, with a 15.82% increase in returns during this period. It has also outperformed the sector by 3.19% today. The stock's intraday high of Rs. 1171.95 shows a high volatility of 94.89%, calculated from the weighted average price. Zydus Lifesciences is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance. In comparison to the Sensex, Zydus Lifesciences has outperformed with a 1-day performance of 2.90% while the Sensex has shown a -0.17% performance. In the last month, the stock has seen a 23.23% increase in performance, while the Sensex has only shown a 1.08% increase. With its consistent growth and positive performance, Zydus Lifesciences is a promising stock in the pharma industry. Investors can consider adding it to their portfolio for potential long-term gains.